The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases

被引:79
|
作者
Sheng, B [1 ]
Cheng, SKW
Lau, KK
Li, HL
Chan, ELY
机构
[1] Princess Margaret Hosp, Dept Med & Geriatr, Kowloon, Hong Kong, Peoples R China
[2] Kwai Chung Hosp, Consultat & Liaison Psychiat Team, Hong Kong, Hong Kong, Peoples R China
[3] Kwai Chung Hosp, Clin Psychol Serv Unit, Hong Kong, Hong Kong, Peoples R China
[4] Caritas Med Ctr, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China
关键词
severe acute respiratory syndrome; steroids; health care workers; mental disorders;
D O I
10.1016/j.eurpsy.2004.06.023
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective. - To evaluate the effects of disease severity, corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients, both during acute and convalescent phases. Subjects and methods. - Self-administered mail questionnaires survey to 308 SARS patients after discharging from hospital. Both patients and their families were asked about symptoms related to various neuropsychiatric domains, and the questions covered both acute and convalescent phases. Results. - Among the 102 (33%) valid replies, 65% had strong symptorns in convalescent phase as indicated by GHQ28 score >= 5. In multiple linear regression analysis, use of pulse steroid and total dosages Of pulse steroid during hospitalisation were predictive for anxiety-depression, psychosis and behavioural symptoms in acute phase, the effects persisted in convalescent phase. Disease severity had direct correlation with symptoms in all neuropsychiatric domains at acute phase and anxiety-depression and cognition at convalescent phase. Health care workers had more neuropsychiatric complaints in both phases. Severity of symptoms, corticosteroids and social factors explained about half of the variances (R-2 = 52) in anxiety-depression at acute phase and 33% at convalescent phase. Conclusion. - Severe disease, high dose corticosteroids and being health care workers were independent predictors of neuropsychiatric complaints in both acute and convalescent phases. (c) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 50 条
  • [21] The risk factors for acute respiratory distress syndrome in patients with severe acute pancreatitis A retrospective analysis
    Zhang, Weiwei
    Zhang, Min
    Kuang, Zhiming
    Huang, Zhenfei
    Gao, Lin
    Zhu, Jianlong
    MEDICINE, 2021, 100 (02) : E23982
  • [22] Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Zhang, Bin
    Liu, Shuyi
    Tan, Tan
    Huang, Wenhui
    Dong, Yuhao
    Chen, Luyan
    Chen, Qiuying
    Zhang, Lu
    Zhong, Qingyang
    Zhang, Xiaoping
    Zou, Yujian
    Zhang, Shuixing
    CHEST, 2020, 158 (01) : E9 - E13
  • [23] Longitudinal analysis of severe acute respiratory syndrome (SARS) coronavirus-specific antibody in SARS patients
    Chang, SC
    Wang, JT
    Huang, LM
    Chen, YC
    Fang, CT
    Sheng, WH
    Wang, JL
    Yu, CJ
    Yang, PC
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (12) : 1455 - 1457
  • [24] Alternative diagnoses in 90 patients admitted for suspicion of severe acute respiratory syndrome (SARS)
    Noel, V
    Emmanuelli, J
    Breton, G
    Longuet, P
    Macrez, A
    Rigolli, B
    Vilde, JL
    Leport, C
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S113 - S114
  • [25] Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid
    Leung, DTM
    Tam, FCH
    Ma, CH
    Chan, PKS
    Cheung, JLK
    Niu, HT
    Tam, JSL
    Lim, PL
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (02): : 379 - 386
  • [26] Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients
    Couturier, Aymeric
    Ferlicot, Sophie
    Chevalier, Kevin
    Guillet, Matthieu
    Essig, Marie
    Jaureguiberry, Stephane
    Collarino, Rocco
    Dargelos, Mathilde
    Michaut, Alice
    Geri, Guillaume
    Roque-Afonso, Anne-Marie
    Zaidan, Mohamad
    Massy, Ziad A.
    CLINICAL KIDNEY JOURNAL, 2020, 13 (03) : 347 - 353
  • [27] Severe Acute Respiratory Syndrome (SARS): A Brief Review With Exploration of the Outcomes, Prognostic Factors and Sequelae
    Chan, Johnny W. M.
    Ng, Chun Kong
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2005, 1 (01) : 85 - 92
  • [28] CASE FATALITY OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) IN MAINLAND CHINA AND ASSOCIATED RISK FACTORS
    de Vlas, Sake J.
    Jia, Na
    Feng, Dan
    Richardus, Jan Hendrik
    Cao, Wu-Chun
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 343 - 343
  • [29] ADVERSE DRUG REACTIONS ASSOCIATED WITH THE USE OF RIBAVIRIN IN THE TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS)
    MacKay, Ian F.
    Garrah, Joanne M.
    Tabah, Bradlee M.
    Freeman, Laura
    Maher, Maurica
    Macdonald, C. Lynn
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2005, 12 (01): : E165 - E179
  • [30] A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus
    Oxford, JS
    Bossuyt, S
    Lambkin, R
    IMMUNOLOGY, 2003, 109 (03) : 326 - 328